From Chemical Stability to Clinical Performance: A Critical Comparison of Topical Vitamin C Derivatives and Skin-delivery Systems
L-ascorbic acid (vitamin C) is widely used in topical formulations for its antioxidant, anti-pigmentation and collagen-promoting properties. However, its susceptibility to oxidation, low-pH formulation requirements and limited penetration through the lipid-rich stratum corneum have encouraged the development of more stable derivatives and advanced delivery systems. This review critically compares topical vitamin C derivatives, particularly tetrahexyldecyl ascorbate (THD ascorbate), in terms of chemical stability, skin delivery, bioconversion and clinical evidence for hyperpigmentation and photoaging. Literature was retrieved from PubMed, Scopus, Web of Science and Wiley Online Library, covering publications from database inception to September 2026. In vitro, ex vivo and clinical studies, alongside relevant reviews, were evaluated based on study design, sample size, formulation vehicles, comparators, outcomes and potential conflicts of interest. A qualitative synthesis was adopted because of study heterogeneity. Lipophilic derivatives demonstrate advantages in formulation compatibility and stability under selected conditions, with improved permeation reported in certain models. However, evidence of intracellular conversion of THD ascorbate to active ascorbic acid remains limited compared with some hydrophilic derivatives. Clinical studies report improvements in pigmentation, skin texture and photoaging markers, although many involve small populations, short durations and multi-ingredient formulations, limiting attribution of individual effects. THD ascorbate represents a promising topical vitamin C derivative with potential stability and delivery advantages; however, its clinical superiority remains unestablished. Standardised comparative studies, human skin bioconversion assessments and larger independent clinical trials are needed to establish its therapeutic potential.
Authors
- M. Murugappan (ORCID: https://orcid.org/0000-0003-3062-6568)
- V Gugan (ORCID: https://orcid.org/0009-0001-6547-6048)
- A Lithika (ORCID: https://orcid.org/0009-0008-6014-255X)
- M S Lohith (ORCID: https://orcid.org/0009-0001-9429-5465)
- Nidhi Ramesh Agarwal (ORCID: https://orcid.org/0009-0001-9226-7073)
Institutions
- JSS Academy of Higher Education and Research (IN)
Publication Details
- Journal
- Journal of Pharmaceutical Innovation
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1007/s12247-026-11165-x
- Primary Topic
- Advancements in Transdermal Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00